Update on SPCs

Event information

Update on SPCs
Start date Thursday, March 26, 2020 12:30 PM
End date Thursday, March 26, 2020 01:30 PM
CPD Points 1.0
Price Non Member £73.20 (Includes £12.20 VAT)
Member £49.20 (Includes £8.20 VAT)

Synopsis

This webinar presented by Duncan Curley will  provide an update on the recent caselaw on SPCs: the end of the Truvada (Gilead v Teva and others) saga; the CJEU decisions of 2019 reviewed; discussion of the latest references; some thoughts on the SPC manufacturing waiver and finally, some speculation about what the future holds for SPCs in the UK, having “taken back control”.  

Speaker Information:

Dr Duncan Curley qualified as a solicitor in 1995.  He subsequently became a partner in the intellectual property department of an international law firm.  He founded the boutique IP legal practice, Innovate Legal, in 2007.  The firm acts for multinational and UK-based generic pharmaceutical companies on patent and trademark issues, including freedom to operate, patent clearance and litigation.  Duncan is the author of numerous published articles on IP issues and a study entitled “Extending Rewards for Innovative Drug Development”, a Report on Supplementary Protection Certificates that was published by the Intellectual Property Institute in 2007.